Meritech Capital Associates V’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-494,236
| Closed | -$9.61M | – | 3 |
|
|
2024
Q2 | $9.61M | Hold |
494,236
| – | – | 3.3% | 3 |
|
|
2024
Q1 | $18.5M | Hold |
494,236
| – | – | 6.2% | 3 |
|
|
2023
Q4 | $27.7M | Hold |
494,236
| – | – | 6.73% | 3 |
|
|
2023
Q3 | $20.4M | Sell |
494,236
-256,266
| -34% | -$10.6M | 6.49% | 3 |
|
|
2023
Q2 | $41.9M | Hold |
750,502
| – | – | 10.04% | 3 |
|
|
2023
Q1 | $41.9M | Sell |
750,502
-311,180
| -29% | -$17.4M | 8.8% | 4 |
|
|
2022
Q4 | $38.7M | Hold |
1,061,682
| – | – | 9.44% | 3 |
|
|
2022
Q3 | $30.2M | Hold |
1,061,682
| – | – | 5.16% | 4 |
|
|
2022
Q2 | $48M | Sell |
1,061,682
-274,571
| -21% | -$12.4M | 7.43% | 4 |
|
|
2022
Q1 | $102M | Sell |
1,336,253
-274,571
| -17% | -$20.9M | 9.59% | 4 |
|
|
2021
Q4 | $240M | Sell |
1,610,824
-183,047
| -10% | -$27.3M | 7.68% | 3 |
|
|
2021
Q3 | $261M | Hold |
1,793,871
| – | – | 7.8% | 3 |
|
|
2021
Q2 | $351M | Sell |
1,793,871
-329,485
| -16% | -$64.5M | 7.51% | 3 |
|
|
2021
Q1 | $384M | Sell |
2,123,356
-457,619
| -18% | -$82.8M | 9.49% | 3 |
|
|
2020
Q4 | $365M | Buy |
+2,580,975
| New | +$365M | 30.7% | 2 |
|